Literature DB >> 9184844

Immunohistochemical identification and comparison of glial cell lineage in foetal, neonatal, adult and neoplastic human adrenal medulla.

G Magro1, S Grasso.   

Abstract

The differentiation of glial cells in developing, neonatal, adult and neoplastic human adrenal medulla has studied immunohistochemically. From 8 to 28 weeks' gestational age, S-100 protein and its beta-subunit revealed two different glial cell populations in adrenal glands, namely Schwann-like and sustentacular cells. Schwann-like cells were spindle-shaped cells forming a continuous layer around groups of sympathetic neuroblasts, often in contact with Schwann cells of nerve fibres entering neuroblastic groups. Sustentacular cells were round or oval cells with dendritic cytoplasmic processes; they were not associated with nerve fibres and mingled both with sympathetic neuroblasts and differentiating chromaffin cells. The developmental fate of Schwann-like cells was different from that of sustentacular cells. Schwann-like cells disappeared from the 28th week of gestational age, in association with the disappearance of sympathetic neuroblastic groups, and they were rarely found in neonatal and adult adrenal medulla. In contrast, sustentacular cells persisted between medullary chromaffin cells, and their number and dendritic cytoplasmic processes progressively increased from foetus to adult. In eight cases of primitive adrenal neuroblastic tumours of neonatal age (five undifferentiated neuroblastomas and three ganglioneuroblastomas), Schwann-like cells were found at the periphery of tumoral nests with a lobular growth pattern, while rare sustentacular cells were associated with neuroblasts. In two cases of adult phaeochromocytomas, only sustentacular cells were detected between chromaffin tumoral cells. Our findings suggest that the glial cell types and their distribution in primitive adrenal medulla tumours closely resemble those observed during development in the groups of adrenal sympathetic neuroblasts and in the clusters of chromaffin cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9184844     DOI: 10.1023/a:1026422514221

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  24 in total

Review 1.  Neural and neuroendocrine phenotype of neuroblastomas, ganglioneuroblastomas, ganglioneuromas and mature versus embryonic human adrenal medullary cells.

Authors:  J Q Trojanowski; W M Molenaar; D L Baker; D Pleasure; V M Lee
Journal:  Prog Clin Biol Res       Date:  1991

2.  The extracellular matrix during neural crest formation and migration in rat embryos.

Authors:  R E Poelmann; A C Gittenberger-de Groot; M M Mentink; B Delpech; N Girard; B Christ
Journal:  Anat Embryol (Berl)       Date:  1990

3.  Histogenesis of the human adrenal medulla. An evaluation of the ontogeny of chromaffin and nonchromaffin lineages.

Authors:  M J Cooper; G M Hutchins; M A Israel
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

4.  Early fetal acquisition of the chromaffin and neuronal immunophenotype by human adrenal medullary cells. An immunohistological study using monoclonal antibodies to chromogranin A, synaptophysin, tyrosine hydroxylase, and neuronal cytoskeletal proteins.

Authors:  W M Molenaar; V M Lee; J Q Trojanowski
Journal:  Exp Neurol       Date:  1990-04       Impact factor: 5.330

5.  Satellite cells in the normal human adrenal gland and in pheochromocytomas. An immunohistochemical study.

Authors:  L Lauriola; N Maggiano; S Sentinelli; F Michetti; D Cocchia
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1985

6.  S100 protein-positive sustentacular cells in malignant and locally aggressive adrenal pheochromocytomas.

Authors:  P Unger; K Hoffman; D Pertsemlidis; S Thung; D Wolfe; M Kaneko
Journal:  Arch Pathol Lab Med       Date:  1991-05       Impact factor: 5.534

7.  Immunocytochemistry of paragangliomas--value of staining for S-100 protein and glial fibrillary acid protein in diagnosis and prognosis.

Authors:  E Achilles; B C Padberg; K Holl; G Klöppel; S Schröder
Journal:  Histopathology       Date:  1991-05       Impact factor: 5.087

8.  Beta 2-microglobulin expression in human embryonal neuroblastoma reflects its developmental regulation.

Authors:  M J Cooper; G M Hutchins; R J Mennie; M A Israel
Journal:  Cancer Res       Date:  1990-06-15       Impact factor: 12.701

9.  Recommendations for modification of terminology of neuroblastic tumors and prognostic significance of Shimada classification. A clinicopathologic study of 213 cases from the Pediatric Oncology Group.

Authors:  V V Joshi; A B Cantor; G Altshuler; E W Larkin; J S Neill; J J Shuster; C T Holbrook; F A Hayes; R P Castleberry
Journal:  Cancer       Date:  1992-04-15       Impact factor: 6.860

10.  Prognostic value of N-myc oncogene amplification and S-100 protein positivity in children with neuroblastic tumors.

Authors:  Y Hachitanda; A Nakagawara; M Nagoshi; M Tsuneyoshi
Journal:  Acta Pathol Jpn       Date:  1992-09
View more
  3 in total

1.  Melatonin activates the vascular elements, telocytes, and neuroimmune communication in the adrenal gland of Soay rams during the non-breeding season.

Authors:  Manal T Hussein; Doaa M Mokhtar; A H S Hassan
Journal:  Protoplasma       Date:  2019-10-22       Impact factor: 3.356

2.  Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma.

Authors:  Selina Jansky; Ashwini Kumar Sharma; Verena Körber; Andrés Quintero; Umut H Toprak; Elisa M Wecht; Moritz Gartlgruber; Alessandro Greco; Elad Chomsky; Thomas G P Grünewald; Kai-Oliver Henrich; Amos Tanay; Carl Herrmann; Thomas Höfer; Frank Westermann
Journal:  Nat Genet       Date:  2021-03-25       Impact factor: 38.330

3.  The cloning and characterization of the enolase2 gene of Gekko japonicus and its polyclonal antibody preparation.

Authors:  Jing Li; Ronghua Wu; Haijiao Chen; Youlang Zhou; Yan Li; Yongjun Wang; Yan Liu; Mei Liu
Journal:  Int J Mol Sci       Date:  2013-04-24       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.